Recombinant multi-species SMAD4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SMAD4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the Smad family of signal transduction proteins. Smad proteins are phosphorylated and activated by transmembrane serine-threonine receptor kinases in response to transforming growth factor (TGF)-beta signaling. The product of this gene forms homomeric complexes and heteromeric complexes with other activated Smad proteins, which then accumulate in the nucleus and regulate the transcription of target genes. This protein binds to DNA and recognizes an 8-bp palindromic sequence (GTCTAGAC) called the Smad-binding element (SBE). The protein acts as a tumor suppressor and inhibits epithelial cell proliferation. It may also have an inhibitory effect on tumors by reducing angiogenesis and increasing blood vessel hyperpermeability. The encoded protein is a crucial component of the bone morphogenetic protein signaling pathway. The Smad proteins are subject to complex regulation by post-translational modifications. Mutations or deletions in this gene have been shown to result in pancreatic cancer, juvenile polyposis syndrome, and hereditary hemorrhagic telangiectasia syndrome. [provided by RefSeq, May 2022]
The Alternative Names of target: D18Wsu70e,DPC4,Deletion target in pancreatic carcinoma 4,JIP,MAD homolog 4,MADH4,MYHRS,Madh4,Mothers against DPP homolog 4,Mothers against decapentaplegic homolog 4,SMAD family member 4 (SMAD 4,SMAD4,Smad4,hSMAD4)
Go
to SMAD4 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP8776-Ag-1/ GM-Tg-hg-IP8776-Ag-2 | Human SMAD4 protein | Human |
| GM-Tg-rg-IP8776-Ag-1/ GM-Tg-rg-IP8776-Ag-2 | Rat SMAD4 protein | Rat |
| GM-Tg-mg-IP8776-Ag-1/ GM-Tg-mg-IP8776-Ag-2 | Mouse SMAD4 protein | Mouse |
| GM-Tg-cynog-IP8776-Ag-1/ GM-Tg-cynog-IP8776-Ag-2 | Cynomolgus/Rhesus macaque SMAD4 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP8776-Ag-1/ GM-Tg-felg-IP8776-Ag-2 | Feline SMAD4 protein | Feline |
| GM-Tg-cang-IP8776-Ag-1/ GM-Tg-cang-IP8776-Ag-2 | Canine SMAD4 protein | Canine |
| GM-Tg-bovg-IP8776-Ag-1/ GM-Tg-bovg-IP8776-Ag-2 | Bovine SMAD4 protein | Bovine |
| GM-Tg-equg-IP8776-Ag-1/ GM-Tg-equg-IP8776-Ag-2 | Equine SMAD4 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP8776-Ag-1/ GM-Tg-hg-IP8776-Ag-2;
GM-Tg-rg-IP8776-Ag-1/ GM-Tg-rg-IP8776-Ag-2;
GM-Tg-mg-IP8776-Ag-1/ GM-Tg-mg-IP8776-Ag-2; GM-Tg-cynog-IP8776-Ag-1/ GM-Tg-cynog-IP8776-Ag-2; GM-Tg-felg-IP8776-Ag-1/ GM-Tg-felg-IP8776-Ag-2; GM-Tg-cang-IP8776-Ag-1/ GM-Tg-cang-IP8776-Ag-2; GM-Tg-bovg-IP8776-Ag-1/ GM-Tg-bovg-IP8776-Ag-2; GM-Tg-equg-IP8776-Ag-1/ GM-Tg-equg-IP8776-Ag-2 |
| Products Name | SMAD4 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | SMAD4 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SMAD4 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.